Results 191 to 200 of about 61,706 (295)

Choroidal vascular hyperpermeability patterns in central serous chorioretinopathy correlate with microperimetry: CERTAIN study report 4

open access: yesActa Ophthalmologica, Volume 104, Issue 3, Page 288-295, May 2026.
Abstract Purpose This report evaluates the association of three distinct leakage patterns of choroidal vascular hyperpermeability (CVH) on indocyanine green angiography (ICGA), previously correlated with disease chronicity, with retinal sensitivity measured by microperimetry in central serous chorioretinopathy (CSC): unifocal indistinct signs of ...
Jennifer M. Chang‐Wolf   +7 more
wiley   +1 more source

Characteristics Analysis of Multifocal Electroretinogram in Non-proliferative Diabetic Retinopathy

open access: yes
Abstract Purpose To investigate multifocal electroretinogram (mfERG) changes in non-proliferative diabetic retinopathy (NPDR) patients compared to normal people, and to clarify the differences in changes across various regions of the retina. Methods We selected 18 healthy individuals (22 eyes) and 26 NPDR patients (45 eyes), using the RETscan
Ziwei Li, Yan Cui
openaire   +1 more source

Customizing AI‐based screening with real‐world data: Practical insights from diabetic retinopathy

open access: yesActa Ophthalmologica, Volume 104, Issue 3, Page 323-332, May 2026.
Abstract Purpose Diabetic retinopathy (DR) is a leading cause of vision loss in middle‐aged adults globally. Although artificial intelligence (AI)‐based screening tools like IDx‐DR (classification) and Thirona RetCAD (regression) have shown high sensitivity in controlled settings, real‐world screening faces challenges due to missing or low‐quality ...
Broder Poschkamp   +17 more
wiley   +1 more source

Emerging Role of Ferroptosis in Diabetes and Associated Complications: When Metabolic Dysregulation Meets Cell Death

open access: yesCell Proliferation, Volume 59, Issue 5, May 2026.
This study identifies ferroptosis as a key driver of diabetes and its complications via iron metabolism and lipid peroxidation, elucidates organelle interactions underlying cell vulnerability, and provides insights for targeted therapies against metabolic disorders.
Zheng Wang   +10 more
wiley   +1 more source

Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3872-3882, May 2026.
Abstract Objective To comprehensively assess the cost‐utility of icodec, the first once‐weekly basal insulin, at 700 and 1050 U formulations compared with once‐daily basal insulin analogues in Chinese adults with type 2 diabetes within reimbursement context.
Xichen Tong   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy